OPKO Health, Inc. Payments for (Proceeds from) Other Investing Activities
OPKO Health, Inc. (OPK) reported Payments for (Proceeds from) Other Investing Activities of -$2.21 million for the 12-month period ending 2017-12-31, per its 8-K filed 2019-01-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2019-01-29
- OPKO Health, Inc. payments for (proceeds from) other investing activities for the quarter ending 2015-12-31 was $0.00.
- OPKO Health, Inc. payments for (proceeds from) other investing activities for the quarter ending 2015-09-30 was $0.00.
- OPKO Health, Inc. payments for (proceeds from) other investing activities for the quarter ending 2015-06-30 was $0.00.
- OPKO Health, Inc. payments for (proceeds from) other investing activities for the quarter ending 2015-03-31 was $0.00.
- OPKO Health, Inc. payments for (proceeds from) other investing activities for fiscal 2014 was -$1.33M.
- OPKO Health, Inc. payments for (proceeds from) other investing activities for fiscal 2013 was -$30.56M.
- OPKO Health, Inc. payments for (proceeds from) other investing activities for fiscal 2012 was $0.00.
- OPKO Health, Inc. payments for (proceeds from) other investing activities for fiscal 2011 was $0.00.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 6 month | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$2.21M 8-K · filed 2019-01-29 | |||
| 2016-12-31 | $0.00 8-K · filed 2019-01-29 | |||
| 2015-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $0.00 derived: sum of 2 quarters · filed 2019-01-29 | $0.00 derived: sum of 3 quarters · filed 2019-01-29 | $0.00 8-K · filed 2019-01-29 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | $0.00 derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $0.00 10-Q · filed 2015-08-05 | $0.00 derived: sum of 3 quarters · filed 2017-03-01 | $0.00 derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $0.00 derived: sum of 3 quarters · filed 2017-03-01 | -$34.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | -$34.00K derived: sum of 3 quarters · filed 2017-03-01 | -$1.33M 10-K · filed 2017-03-01 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$34.00K derived: sum of 2 quarters · filed 2015-11-09 | -$1.33M 10-Q · filed 2015-11-09 | -$20.26M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$1.33M 10-Q · filed 2015-08-05 | -$20.26M derived: sum of 3 quarters · filed 2016-02-29 | -$20.39M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$1.30M 10-Q · filed 2015-05-11 | -$20.23M derived: sum of 2 quarters · filed 2016-02-29 | -$20.36M derived: sum of 3 quarters · filed 2016-02-29 | -$29.32M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$18.93M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$19.06M derived: sum of 2 quarters · filed 2016-02-29 | -$28.03M derived: sum of 3 quarters · filed 2016-02-29 | -$30.56M 10-K · filed 2016-02-29 |
| 2013-09-30 | -$132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$9.10M derived: sum of 2 quarters · filed 2014-11-07 | -$11.63M 10-Q · filed 2014-11-07 | -$11.63M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | -$8.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$11.50M 10-Q · filed 2014-08-11 | -$11.50M derived: sum of 3 quarters · filed 2015-02-27 | |
| 2013-03-31 | -$2.53M 10-Q · filed 2014-05-09 | -$2.53M derived: sum of 2 quarters · filed 2015-02-27 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $0.00 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-12 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |